Visiting speaker Kelly Chibale, Ph.D., Professor, Organic Chemistry, University of Cape Town, will give the following three presentations at (VUMC) on Monday, June 18. 

3:00 - 4:00 pm  |  A2200 Medical Center North 
“Discovery of Africa’s first small molecule clinical drug candidate for malaria”

Kelly Chibale is a Full Member of the UCT Institute of Infectious Disease & Molecular Medicine (IDM), a Tier 1 South Africa Research Chair in Drug Discovery, founding Director of the South African Medical Research Council (SAMRC) Drug Discovery and Development Research Unit at UCT and the Founder and Director of the UCT Drug Discovery and Development Centre (H3D).

Dr. Chibale obtained his PhD in Synthetic Organic Chemistry from the University of Cambridge in the UK (1989-1992). This was followed by postdoctoral stints at the University of Liverpool in the UK (1992-94) and at the Scripps Research Institute in the USA (1994-96). He was a Sandler Sabbatical Fellow at the University of California San Francisco (2002), a US Fulbright Senior Research Scholar at the University of Pennsylvania School of Medicine (2008) and a Visiting Professor at Pfizer in the UK (2008). He was also recently named as one of Fortune Magazine’s 50 World’s Greatest Leaders for 2018.  

Dr. Chibale's presentations are hosted by the Vanderbilt TB Center, the Division of Infectious Disease, and the Vanderbilt School of Medicine. Visit sponsored by the Glenn Koenig Memorial Fund.